Norikura, T., Kojima-Yuasa, A., Shimizu, M., Huang, X., Xu, S., Kametani, S., Rho, S.K., Kennedy, D.O. and Matsui-Yuasa, I. (2008) Anticancer activity and mechanisms of Blumea balsamifera extract in hepatocellular carcinoma cells. The American Journal of Chinese Medicine, 36, 411-424. doi:10.1142/S0192415X08005862

has been cited by the following article:

• TITLE: Analysis of apigenin in Blumea balsamifera Linn DC. and its inhibitory activity against aldose reductase in rat lens

  AUTHORS: Dong Gu Lee, So-Youn Mok, Changsun Choi, Eun Ju Cho, Hyun Young Kim, Sanghyun Lee

  KEYWORDS: Blumea balsamifera; Apigenin; Aldose Reductase Inhibition; HPLC

  JOURNAL NAME: Journal of Agricultural Chemistry and Environment, Vol.1 No.1, November 28, 2012

  ABSTRACT: To investigate the therapeutic potentials of na- tural sources, stepwise polarity fractions of Blumea balsamifera were tested for their ability to inhibit aldose reductase (AR) activity in rat lenses. Of these, the ethyl acetate (EtOAc) fraction exhibited a unique AR inhibitory activity (IC50 value, 0.11 μg/mL). Apigenin was identified from the active EtOAc fraction and exhibited high AR inhibitory activity (IC50 value, 4.03 μM). The content of apigenin was measured in B. balsamifera (0.47 mg/g) by HPLC/UV analysis. Our result suggests that B. balsamifera could be a useful natural source for the development of a novel AR inhibitory agent against diabetic complications.